Combining Clinical and Molecular Data to Predict the Benefits of Carmustine Wafers in Newly Diagnosed High-Grade Gliomas

被引：0
|
作者：
Tamara Ius
Daniela Cesselli
Miriam Isola
Giovanni Toniato
Giada Pauletto
Giovanni Sciacca
Sara Fabbro
Enrico Pegolo
Simona Rizzato
Antonio Paolo Beltrami
Carla di Loreto
Miran Skrap
机构：
[1] Santa Maria della Misericordia University Hospital,Neurosurgery Unit, Department of Neurosciences
[2] University of Udine,Department of Medicine
[3] Santa Maria della Misericordia University Hospital,Neurology Unit, Department of Neurosciences
[4] Santa Maria della Misericordia University Hospital,Department of Oncology
[5] Santa Maria della Misericordia University Hospital,Institute of Pathology
来源：
Current Treatment Options in Neurology | 2018年 / 20卷
关键词：
Glioma surgery; Carmustine wafers; MGMT methylation; Overall survival;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Combining Clinical and Molecular Data to Predict the Benefits of Carmustine Wafers in Newly Diagnosed High-Grade Gliomas
    Ius, Tamara
    Cesselli, Daniela
    Isola, Miriam
    Toniato, Giovanni
    Pauletto, Giada
    Sciacca, Giovanni
    Fabbro, Sara
    Pegolo, Enrico
    Rizzato, Simona
    Beltrami, Antonio Paolo
    di Loreto, Carla
    Skrap, Miran
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2018, 20 (02)
  • [2] Newly Diagnosed High-Grade Gliomas
    Giglio, Pierre
    Villano, John Lee
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2010, 12 (04) : 309 - 320
  • [3] Newly Diagnosed High-Grade Gliomas
    Pierre Giglio
    John Lee Villano
    Current Treatment Options in Neurology, 2010, 12 : 309 - 320
  • [4] Carmustine implants for the treatment of newly diagnosed high-grade gliomas - A cost-utility analysis
    Rogers, Gabriel
    Garside, Ruth
    Mealing, Stuart
    Pitt, Martin
    Anderson, Rob
    Dyer, Matthew
    Stein, Ken
    Somerville, Margaret
    PHARMACOECONOMICS, 2008, 26 (01) : 33 - 44
  • [5] Caring for Patients with Newly Diagnosed High-Grade Gliomas
    Grossman, Stuart A.
    Piotrowski, Anna F.
    SEMINARS IN NEUROLOGY, 2016, 36 (04) : 324 - 329
  • [6] Adults with newly diagnosed high-grade gliomas.
    Croteau D.
    Mikkelsen T.
    Current Treatment Options in Oncology, 2001, 2 (6) : 507 - 515
  • [7] Carmustine Wafers Implantation in Patients With Newly Diagnosed High Grade Glioma: Is It Still an Option?
    Ricciardi, Luca
    Manini, Ivana
    Cesselli, Daniela
    Trungu, Sokol
    Piazza, Amedeo
    Mangraviti, Antonella
    Miscusi, Massimo
    Raco, Antonino
    Ius, Tamara
    FRONTIERS IN NEUROLOGY, 2022, 13
  • [8] Iatrogenic immunosuppression in patients with newly diagnosed high-grade gliomas
    Grossman, S. A.
    Desideri, S.
    Ye, X.
    Szajna, K.
    Chamberlain, M.
    Lesser, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [9] Fotemustine-dacarbacine in newly diagnosed high-grade gliomas
    Hassler, M. R.
    Fazeny-Doerner, B.
    Elandt, K.
    Piribauer, M.
    Preusser, M.
    Hainfellner, J. A.
    Dieckmann, K.
    Rössler, K.
    Marosi, C.
    NEURO-ONCOLOGY, 2006, 8 (04) : 347 - 347
  • [10] Survival outcomes and safety of carmustine wafers in the treatment of high-grade gliomas: a meta-analysis
    Sajeel A. Chowdhary
    Timothy Ryken
    Herbert B. Newton
    Journal of Neuro-Oncology, 2015, 122 : 367 - 382
12345